Because Th17-associated cytokines play a central role in defense against extracellular infections at mucosal sites, we propose that, in tissues such as the lung, the dual capacity of glucocorticoids to both maintain at least certain antimicrobial defense mechanisms via IL-17A and IL-22, as well as dampen inflammation via IL-10, is highly desirable. The gene discussed is IL17A; the disease is infection.